Jr., and Gurgueira, S.A., Clin
Hold the vial against white paper for the clearest view
New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation June 23, 2025 CHICAGO Research indicates potential for new wave of breakthroughs in maintaining lean mass for patients taking GLP-1-based medications Findings from two groundbreaking studies highlight potential pharmacological and biosensor solutions for muscle mass preservation in patients undergoing obesity treatment therapy
Effective January 1, 2027, the "decision applies to all doses of these medicines and reflects Novo Nordisk's commitment to enhancing affordability for patients and both public and private payers dealing with the complexities of the evolving US healthcare system," the company said in a statement
To view a copy of this licence, visit About this article Cite this article Karam, L., Mabilleau, G
Thats it for today